Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Aurora Cannabis Inc. (ACB) vs Organogenesis (ORGO)

Aurora Cannabis Inc. and Organogenesis are both Drug Manufacturers Specialty & Generic companies. Aurora Cannabis Inc. is the larger, with a market value of $267.8M against $207.1M — 1.3× the size. Organogenesis grew revenue faster over the last twelve months: 6.50% against −18.2%. Organogenesis has the higher net margin (−22.2% vs −38.1%) and the lower return on invested capital (−20.0% vs −5.58%). Across the 19 metrics below, Organogenesis leads on 12 and Aurora Cannabis Inc. on 7.

Valuation

Metric ACB ORGO Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 1.20 0.39 2.25
P/B 0.66 1.22 1.90
Price to free cash flow n/m 8.64 16.54
EV/EBITDA n/m n/m 12.29
EV/Sales 0.96 0.33 2.56
Earnings yield (34.39%) (60.71%) (2.99%)
Free cash flow yield (14.28%) 11.57% 0.00%

Profitability

Metric ACB ORGO Drug Manufacturers Specialty & Generic median
Gross margin 49.74% 70.35% 53.94%
Operating margin (12.13%) (7.84%) 0.00%
Net margin (38.12%) (22.23%) 0.00%
Free cash flow margin (17.19%) 4.56% 0.00%
Return on equity (19.85%) (53.31%) (0.40%)
Return on assets (15.19%) (23.44%) (3.32%)
Return on invested capital (5.58%) (19.97%) 0.00%

Growth

Metric ACB ORGO Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (18.18%) 6.50% 10.01%
EPS growth (last fiscal year) (5,266.67%) 1,600.00% —
Revenue growth, 5-year CAGR 3.92% 10.77% 6.74%
Net income growth, 5-year CAGR 0.00% 3.04% 0.00%

Health

Metric ACB ORGO Drug Manufacturers Specialty & Generic median
Debt to equity 0.03 0.07 0.05
Current ratio 5.36 3.52 2.31
Net debt to EBITDA 5.11 (1.14) 0.85

Dividend

Metric ACB ORGO Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric ACB ORGO Drug Manufacturers Specialty & Generic median
Market cap 267.79m 207.13m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack